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SUMMARY 
Regulated or programmed cell death is defined as an intracellular program that plays a 
complementary role to mitosis in maintaining a stable population of cells. Apoptosis is the main form 
of regulated cell death, allowing the silent elimination of harmed or aged cells without triggering any 
inflammatory response.  
Anoctamin 6 (ANO6, TMEM16F) is a multifunctional protein from a family of ten members, 
identified as an endogenous Ca2+-activated Cl- channel (CaCC). Apart from its function as a CaCC, 
ANO6 is also described as a volume-regulated and outwardly rectifying Cl- channel (ORCC), a non-
selective cation channel and a Ca2+-dependent phospholipid scramblase. It has an ubiquitous expression, 
being involved in many physiological processes including apoptosis. Nonetheless, ANO6 role in this 
process is not entirely understood. 
The Cystic Fibrosis Transmembrane conductance Regulator (CFTR) is a cyclic adenosine 
monophosphate (cAMP)-gated Cl- channel expressed in the apical membrane of epithelial cells from the 
intestine, pancreas, airways and sweat glands, where it is responsible to maintain ion and fluid 
homeostasis. Moreover, it regulates the intracellular redox status, acidification and ceramide content in 
lipid rafts, three different functions that may explain CFTR involvement in apoptosis. Mutations in the 
CFTR gene are the cause for Cystic Fibrosis (CF), the most common life-threatening autosomal 
recessive disease in Caucasians. 
Understanding ANO6 and CFTR role in regulated cell death may help to overcome the apoptotic 
dysfunction found in Cystic Fibrosis. Here it is shown that ANO6 is activated by ROS (Reactive Oxygen 
Species) during apoptosis, acting as a Ca2+-activated Cl- channel, non-selective cation channel and 
phospholipid scramblase in different in vitro systems. The channel has a dual contribution for this 
process, transporting ions to the extracellular space and mediating phosphatidylserine (PS) exposure in 
the outer membrane leaflet. Furthermore, a CFTR contribution to ROS-mediated apoptosis was found 
in CFBE cells, a mechanism independent of pore opening and channel stimulation. Co-expression 
studies of ANO6 and CFTR in HEK293 cells revealed a functional relationship of these proteins during 
ROS-mediated apoptosis not only in terms of whole-cell current but also regarding phospholipid 
scrambling. 
A possible interaction between ANO6 and CFTR is also proposed to explain why cells 
overexpressing both proteins have an enhanced spontaneous and ROS-induced apoptosis. Exposure of 
cells to oxidative stress and consequent ROS production leads to mitochondrial permeabilization, release 
of Ca2+ and pro-apoptotic proteins, responsible for caspase cleavage. These events terminate with ANO6 
activation, which may support cell shrinkage and phospholipid scrambling, two apoptotic hallmarks 
enhanced in the presence of CFTR. 
Key-words: Regulated cell death, Apoptosis, Anoctamin 6, CFTR, Cystic Fibrosis 
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RESUMO 
A morte celular programada é um mecanismo homeostático que desempenha um papel 
complementar à mitose na manutenção de uma população estável de células nos tecidos e órgãos. Este 
programa é ativado diariamente, removendo milhões de células danificadas ou envelhecidas. A apoptose 
é considerada a forma predominante de morte celular programada, garantindo a eliminação silenciosa 
de células, isto é, sem ativação do sistema imune. 
Durante a apoptose, as células sofrem uma grande variedade de modificações morfológicas e 
bioquímicas. Estas alterações são em grande parte mediadas por uma família de proteases conhecida por 
caspases. As caspases são normalmente expressas como precursores inativos ou procaspases, que 
adquirem atividade proteolítica na presença de um determinado estímulo. Depois de ativos, estes 
enzimas clivam outras procaspases, proteínas essenciais e ADN, sendo assim responsáveis pela 
amplificação da cascata apoptótica. A clivagem de todos estes substratos resulta na alteração fenotípica 
das células apoptóticas, as quais passam a apresentar uma redução no seu volume (shrinkage), 
condensação de cromatina e formação de protrusões na membrana plasmática (blebbing). 
A composição fosfolipídica da membrana plasmática é também afetada durante a apoptose. Numa 
célula viável, a bicamada lipídica é assimétrica: a fosfatidilserina (PS) e a fosfatidiletanolamina (PE) 
estão presentes no folheto interno, enquanto a fosfatidilcolina (PC) e a esfingomielina (SM) localizam-
se no folheto externo. Esta assimetria é destruída pelo transporte bidirecional de fosfolípidos através da 
membrana plasmática, mediado por scramblases (scrambling). Particularmente, durante a apoptose, a 
PS é movida do folheto interno para o folheto externo, o que serve de sinal para a fagocitose das células 
apoptóticas, um processo essencial para a manutenção da integridade do hospedeiro. 
A Anoctamina 6 (ANO6) é uma proteína ubíqua e multifuncional pertencente a uma família proteica 
formada por dez membros homólogos entre si (ANO1-10; TMEM16 A-K). Esta é identificada como um 
canal de cloreto regulado por volume e ativado por cálcio (do inglês: Calcium activated Chloride 
Channel – CaCC), canal catiónico não seletivo, componente do ORCC (do inglês: Outwardly Rectifying 
Chloride Channel) e scramblase de fosfolípidos ativada por cálcio. A ANO6 participa numa enorme 
variedade de processos biológicos, tais como a coagulação sanguínea, desenvolvimento do esqueleto, 
regulação do volume e migração celular, entre outros. A identificação da ANO6 como uma scramblase 
de fosfolípidos levantou várias questões acerca do seu envolvimento na apoptose. Diferentes estudos 
indicam que esta proteína contribui para este processo como um canal iónico, participando 
eventualmente no shrinkage das células e na ativação de caspases. No entanto, no que diz respeito à sua 
função como scramblase, o papel da ANO6 é ainda incerto. 
O CFTR (do inglês: Cystic Fibrosis Transmembrane conductance Regulator) é um canal de cloreto 
regulado por cAMP (Adenosina de monofosfato cíclico), expresso na membrana apical de células 
epiteliais do intestino, pâncreas, vias respiratórias e glândulas sudoríparas. Mutações no gene que 
codifica para esta proteína são a causa da Fibrose Quística, a doença mortal autossómica recessiva 
responsável pelo maior número de mortes na população caucasiana. Apesar da enorme diversidade de 
variantes de mutações identificadas (cerca de 1.500), a deleção de um resíduo de fenilalanina (F) no 
codão 508 localizado no cromossoma 7 (ΔF508) é encontrada em 90% dos pacientes com Fibrose 
Quística. Esta mutação resulta num folding aberrante do CFTR e consequentemente um defeito no seu 
tráfego do retículo endoplasmático para a membrana plasmática. 
A Fibrose Quística é principalmente caracterizada por uma por uma perturbação da homeostase 
iónica e fluídica. De entre os variados sintomas encontrados nos pacientes afetados, destaca-se a 
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produção excessiva de muco espesso, infeções persistentes nas vias respiratórias pela bactéria 
Pseudomonas aeruginosa, infertilidade masculina e insuficiência pancreática e intestinal. Apesar dos 
esforços contínuos em compreender o CFTR a um nível funcional e molecular, a Fibrose Quística 
continua a ser considerada uma doença letal. A atenuação dos sintomas permitiu aumentar a esperança 
média de vida para cerca de 37 anos. No entanto, a doença pulmonar crónica e a resultante perda de 
função pulmonar continuam a ser os principais problemas por resolver, sendo responsáveis por 80% da 
mortalidade. 
Curiosamente, o CFTR foi previamente descrito como um regulador do estado redox intracelular, 
da acidificação do citoplasma e organelos e dos níveis de ceramida nas jangadas lipídicas, três processos 
determinantes para a apoptose e possivelmente responsáveis pela disfunção apoptótica encontrada na 
Fibrose Quística. Apesar de algumas observações não serem coerentes, a maioria dos estudos defende 
que mutações no CFTR aumentam a suscetibilidade das células para uma morte necrótica. 
Contrariamente ao que se sucede na apoptose, durante a necrose os componentes celulares são libertados 
para os tecidos circundantes e o sistema imune é ativado. Desta forma, especula-se que esta disfunção 
pode contribuir para as inflamações persistentes que caracterizam a Fibrose Quística. 
A interação do CFTR com outros canais e proteínas transportadoras tem sido tópico de investigação 
ao longo dos anos. De entre as proteínas identificadas, destaca-se o ORCC, um canal inativo em células 
viáveis e envolvido no shrinkage e scrambling de fosfolípidos durante a apoptose. Em 2010 Martins et. 
al identificou a ANO6 como componente do ORCC, existindo uma possível interação entre esta proteína 
e o CFTR.  
Tendo em conta todas estas evidências, o objetivo deste projeto foi o estudo da relação entre a ANO6 
e o CFTR durante a morte celular programada. Particularmente, o trabalho focou-se na apoptose 
induzida por ROS (do inglês: Reactive Oxygen Species), uma vez que o CFTR é descrito como um 
regulador do estado redox intracelular. 
A primeira fase deste projeto baseou-se no estudo do impacto dos ROS na atividade da ANO6, não 
só em termos de corrente elétrica, mas também no que diz respeito à sua função de scramblase. Com 
este objetivo, a expressão endógena da ANO6 foi manipulada em células HEK293 e HeLa e a sua função 
foi analisada por patch clamp ou citometria de fluxo, após tratamento com diferentes indutores de stress 
oxidativo. Os resultados demonstraram que a ANO6 é ativada por ROS, transportando cloreto e catiões 
para o espaço extracelular no início da apoptose, um evento que contribui para o shrinkage das células. 
À medida que a via apoptótica avança, a ANO6 passa também a funcionar como scramblase, movendo 
a PS para o folheto externo da membrana plasmática. Como o silenciamento da ANO6 não diminuiu a 
morte celular, é concluído que esta proteína não é absolutamente essencial para a apoptose mediada por 
ROS. No entanto, esta observação não é surpreendente, visto que a morte celular programada é um 
processo essencial em qualquer sistema biológico, dependendo de uma grande variedade de moléculas 
e componentes. Assim, é muito provável que uma célula que não expresse a ANO6 compense este 
defeito com outras proteínas. 
A segunda parte deste trabalho focou-se na importância do CFTR para apoptose mediada por ROS 
e a identificação de uma possível interação funcional entre esta proteína e a ANO6. Estudos de co-
expressão em células HEK293 revelaram que a presença das duas proteínas aumenta a corrente elétrica 
induzida por ROS e intensifica o scrambling de fosfolípidos durante a apoptose. Curiosamente, a co-
expressão da ANO6 e do CFTR revelou ser suficiente para induzir uma apoptose significativa em 
condições controlo. Adicionalmente, a linha celular CFBE estavelmente transfetada com CFTR wt ou 
ΔF508 foi escolhida como uma ferramenta para o estudo da influência da mutação mais proeminente da 
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Fibrose Quística na apoptose. A indução de stress oxidativo nas duas linhas celulares demonstrou que a 
expressão do CFTR wt intensifica a apoptose, um fenómeno independente da abertura do poro e ativação 
do canal. 
Em suma, este estudo permitiu demonstrar que a ANO6 e o CFTR cooperam durante a apoptose 
mediada por ROS. Estas duas proteínas revelaram ter uma relação funcional no que diz respeito à 
ativação de uma corrente iónica e também ao scrambling de fosfolípidos. É especulado que a expressão 
do CFTR na membrana plasmática aumenta a atividade da ANO6, envolvida nestes dois fenómenos 
apoptóticos. No entanto, é também provável que o contrário seja verdade, visto que a ANO6 foi já 
identificada como componente das correntes induzidas por cAMP em células que expressam o CFTR. 
A compreensão do papel da ANO6 e do CFTR durante a morte celular programada pode servir de motor 
para obter uma nova visão acerca da disfunção apoptótica encontrada na Fibrose Quística e, 
eventualmente, desenvolver novas terapias como tentativa de atenuar o processo inflamatório. 
Palavras-chave: Morte programada celular, Apoptose, Anoctamina 6, CFTR, Fibrose Quística 
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1. INTRODUCTION 
1.1 REGULATED CELL DEATH – APOPTOSIS   
Multicellular organisms maintain a stable population of cells during their lifespan, keeping a tight 
control between cell division and cell death. Every day the activation of an intracellular death 
mechanism leads to the elimination of billion harmed or aged cells, which are no longer needed. This 
process is known as regulated or programmed cell death and can be divided into several types, being 
apoptosis the most predominant and studied form1–5. 
Apoptosis was named in 1972 by Kerr and co-workers6, after a Greek word used to describe the 
dropping of leaves from trees, suggesting that cell loss is beneficial for the survival of the host. The 
authors intended to distinguish this process from a different type of cell death known as necrosis. Unlike 
apoptosis, where cell removal happens without compromising the whole organism, necrosis is a highly 
immunogenic mechanism. Furthermore, it is considered as the result of a persistent stimulus which leads 
to an accidental cell death, whereas apoptosis is genetically determined1,6–8.  
The apoptotic pathway involves several molecules and organelles, which are believed to be 
conserved in all animals5. Inside this group, caspases play a major role. This family of proteases is 
normally expressed as inactive precursors or procaspases, which acquire proteolytic activity in the 
presence of a specific stimulus. Once active, these enzymes amplify the apoptotic pathway by cleaving 
other procaspases and intracellular key prote ins at specific aspartic residues. Regarding apoptosis, 
caspases can be divided in two classes: initiator (caspase-2, 8, 9 and 10) and executioner (caspase-3, 6 
and 7). The first group is responsible to activate the executioner caspases, which will then cleave a wide 
variety of substrates, leading to the final cell death1,8,9. 
The phenotype of an apoptotic cell is mainly characterized by reduced volume, or shrinkage, 
chromatin condensation and membrane blebbing1,7,8,10,11. After these transformations, the cytoplasm and 
organelles are tightly condensed into apoptotic bodies, keeping their integrity. Once these structures are 
formed, they are quickly engulfed by phagocytes (Fig. 1.1) and digested in phagolysosomes, without 
production of anti-inflammatory cytokines. This allows the protection of the surrounding tissue from 
potential released proteases and oxidizing molecules, avoiding inflammation1,7. 
 
Figure 0.1. Representation of morphological transformations occurring during apoptosis and engulfment of the dying 
cell by phagocytes. Initiator caspases activate executioner or effector caspases, able to cleave cellular substrates. As a 
consequence, the apoptotic cell shows reduced volume, DNA damage and fragmentation into apoptotic bodies, which are 
engulfed by phagocytes. Retrieved and adapted from Fink et. al8. 
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Apoptosis can be divided in two main signaling pathways: the intrinsic or mitochondrial pathway 
and the extrinsic or death receptor pathway. The first is activated when cells are exposed to inner stress 
forms, such as irradiation, heat shock or reactive oxygen species (ROS)1,2. During this mechanism, the 
mitochondrial permeability transition pore (MPTP) is opened, leading to the loss of the mitochondrial 
transmembrane potential and a stop in the ATP (Adenosine Triphosphate) synthesis12. Pro-apoptotic 
proteins are then released to the cytosol which can either function as activators of caspase-9 (e.g. cyt c 
– cytochrome c) or as mediators of DNA (Deoxyribonucleic acid) fragmentation (e.g. AIF – Apoptosis 
Inducing Factor)1.  On the other hand, the extrinsic pathway is activated once specific ligands bind to 
their complementary plasma membrane receptors, such as TNF (Tumor Necrosis Factor) to TNF-R 
(TNF Receptor) or Fas ligand to CD95 (Fas ligand receptor). In this mechanism caspase-8 and 10 are 
major players13. Both signaling pathways end with the activation of executioner caspases, which leads 
to protein and DNA fragmentation and the consequent morphological transformations seen in apoptotic 
cells1. Caspase-3 is considered a key member of this group, being activated by caspase-8, 9 and 101 (Fig. 
1.2). 
.  
Figure 0.2. Extrinsic and intrinsic apoptotic pathways. Ligand binding to transmembrane death receptors activates the 
extrinsic pathway, whereas intracellular stress triggers mitochondrial apoptosis. Both biochemical cascades begin with the 
activation of initiator caspases (caspase-8 and 9, respectively), which catalyze the proteolytic maturation of executioner 
caspases (caspase-3). The intrinsic pathway is characterized by mitochondrial membrane permeabilization (MMP), resulting 
in the release of pro-apoptotic proteins into the cytosol, such as cyt c. The innteraction of cyt c with the adaptor protein apoptotic 
peptidase activating factor 1 (APAF 1) and procaspase 9 form the apoptosome structure, responsible for the activation of 
caspase-9 and consecutively caspase-3. Retrieved and adapted from Galluzzi et. al14. 
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The activation of the apoptotic pathway is followed by modifications in the phospholipid 
composition of the plasma membrane. Normally, the inner leaflet consists of phosphatidylserine (PS) 
and phosphatidylethanolamine (PE), whereas phosphatidylcholine (PC) and sphingomyelin (SM) are 
present in the outer leaflet. Phospholipid transport across the plasma membrane is maintained by three 
different classes of proteins: flippases, floppases and scramblases. Flippases and floppases move 
phospholipids in a single direction against a concentration gradient, requiring ATP to maintain 
membrane asymmetry. The first class is responsible for the transport of PS and PE from the outer to the 
inner leaflet, whereas floppases move PC and SM in the opposite direction. Finally, scramblases are 
responsible for a bidirectional transport, acting according to the concentration gradient15,16 (Fig. 1.3). 
The disruption of this asymmetry leads to the activation of immune cells17, coagulation cascade15, 
exocytosis and apoptosis1,17.  Particularly, during apoptosis, scramblases transport PS across the lipid 
bilayer to the outer leaflet. This process is known as the “eat me signal”, since it serves as a platform for 
the engulfment of the dying cells by phagocytes1,15. 
 
Figure 0.3. Schematic representation of the function of flippases, floppases and scramblases. Flippases move PS and PE 
from the outer to the inner leaflet, whereas floppases transport PC and SM in the opposite direction, using energy from ATP 
hydrolysis. Scramblases are ATP-independent and move phospholipids in both directions according to a concentration gradient.  
 
1.2 ANOCTAMIN 6 – A UNIQUE MEMBER OF THE ANOCTAMIN FAMILY 
Anoctamin 6 (ANO6, TMEM16F) is a particular member of the Anoctamins, a family of ten proteins 
(ANO1-10, TMEM16 A-K). ANO1, ANO2 and ANO6 have been identified as endogenous Ca2+-
activated Cl- channels (CaCC)18–20. It is a dimeric plasma membrane protein with ten transmembrane α-
helices and a pore loop21. ANO6 is homologous to ANO1, sharing a high sequence identity in the 
putative transmembrane-spanning domains of the pore region22. Apart from its function as a CaCC, 
ANO6 is also described as a volume-regulated23–25 and outwardly rectifying Cl- channel (ORCC)26, a 
non-selective cation channel27 and a Ca2+-dependent phospholipid scramblase28,29. Because it is a 
multifunctional protein and has an ubiquitous expression22, ANO6 became an interesting subject for 
investigation. 
Missense mutations in the TMEM16F gene and production of a defective ANO6 are the cause for 
the Scott Syndrome, a rare congenital bleeding disorder. Platelets from patients with Scott Syndrome 
are unable to scramble PS, a process required for the activation of coagulation factors and to keep a 
regular hemostasis29–31. Studies in mice revealed that knockout of the TMEM16F gene results in an 
increased bleeding time due to a suppression of platelet activation27. Moreover, ANO6 is not only 
involved in blood coagulation, but also in skeletal development32, apoptosis23,26,33,34, volume 
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regulation23,24, microparticle shedding22, innate immunity in macrophages35, breast cancer36, cell 
blebbing35 and migration37.  
Despite all the research, ANO6 mechanism of action is still not completely understood. Although it 
is clear that high intracellular Ca2+ concentrations are required, it is unknown if Ca2+ activates ANO6 
directly or through another Ca2+-dependent molecule19. Another unresolved question is the structure of 
this protein and how it is able to transport lipids through an ion-conductive pore. Interestingly, Whitlock 
et. al suggests that all anoctamins evolved from phospholipid scramblases and acquired ion channel 
activity after structural rearrangements. It is possible that the ANO6 pore has a dual molecular 
composition (lipid and protein) that allows the transport of amphipathic molecules, an idea known as 
the proteolipidic pore hypothesis. In this regard, the ANO6 ion currents are probably just the result of 
ions that flow across the plasma membrane together with phospholipids38. This model is supported by 
crystallization of a fungal TMEM16 lipid scramblase homologue, nhTMEM16, a protein formed by ten 
transmembrane domains and a pore loop. It was found that the pore has a proteolipidic nature, having a 
hydrophilic region next to the lipid bilayer, surrounded by two transmembrane helices21,38 (Fig. 1.4). 
 
Figure 0.4. Model of Anoctamin structure and ANO6 pore. A) Topology of the Anoctamin homologue in Nectria 
haematococca, nhTMEM16. This structure is formed by ten transmembrane domains with a pore loop (green) and the N- and 
C-terminal domains in the cytosol (blue and red, respectively). Retrieved from Brunner et al.21. B) Cartoon showing the possible 
proteoplypidic furrow of ANO6 pore, viewed from the extracellular space. The particular molecular composition of the pore 
allows the transport of phospholipids and ions across the plasma membrane – along with ions, phospholipid head groups interact 
with the protein content of the furrow, whereas acyl chains are projected into the hydrophobic bilayer. Retrieved from Whitlock 
et.al.38 
 
1.2.1 Role of Anoctamin 6 in Apoptosis 
The identification of ANO6 as a Ca2+-dependent phospholipid scramblase28,29 raised questions about 
the involvement of this protein in apoptosis. Remarkably, ANO6 has a marked expression in the surface 
of epithelial cells from mouse colon, which have a high apoptosis rate, compared to colonic crypt cells, 
known to have a fast proliferation26. 
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In this regard, ANO6 was found to be a component of the ORCC, an ubiquitous ion channel known 
to be inactive in healthy cells and activated during apoptosis, leading to cell shrinkage and phospholipid 
scrambling22,26. As a matter of fact, Martins et. al proved that stimulation of both intrinsic and extrinsic 
apoptotic pathways activate ANO6-dependent currents in T Lymphocytes, human alveolar and airway 
epithelial cells. These currents were sensitive to the broad anoctamin inhibitors and completely 
abolished by ANO6 downregulation26. The same pattern was found in Xenopus Oocytes overexpressing 
ANO6 after stimulation with Paraquat, a ROS donor22.  
In parallel, Juul et. al observed a decrease in cisplatin-induced caspase-3 activity after knockdown 
of ANO6 in ELA cells23. This protein is known to be involved in RVD (Regulatory Volume Decrease)23–
25 and many channels important for this process are also relevant for AVD (Apoptotic Volume 
Decrease). Therefore, it was speculated that ANO6 facilitates apoptosis by mediating cell shrinkage23.  
Different studies show a clear contribution of ANO6 to apoptosis as an ion channel26,34. However, 
investigations in B Lymphocytes revealed that this protein is not crucial to the PS exposure detected in 
apoptotic cells34. Cell death is a fundamental process in all living systems and it is very likely that other 
proteins contribute for this process, compensating possible defects. It is now known that ANO3, 4, 7, 9 
and 10 are also phospholipid scramblases22,39 and, aside from the anoctamin family, XkR8 (Xk-related 
protein 8) is also reported to be responsible for phospholipid scrambling during apoptosis40.  
1.3 CFTR 
1.3.1 CFTR and Cystic Fibrosis – An Overview 
Cystic Fibrosis (CF) is the most common life-threatening autosomal recessive disease in Caucasians, 
affecting around 70,000 people worldwide41. It is caused by mutations in the CFTR gene (Cystic Fibrosis 
Transmembrane conductance Regulator) and is mainly characterized by an imbalance of ion and fluid 
homeostasis42. This gene encodes for a cyclic AMP (cAMP)-regulated Cl- channel expressed in the 
apical membrane of epithelial cells from the intestine, pancreas, airways and sweat glands43. 
Principal symptoms of CF include: production of thick mucus and subsequent infection by 
Pseudomonas aeruginosa in the airways; pancreatic insufficiency with obstruction of pancreas ducts 
and damage of the exocrine function; intestine impairment; elevated concentration of electrolytes in 
sweat and male infertility41,44. 
So far around 1,500 variants of mutations in the CFTR gene have been identified. Despite this 
diversity, a deletion of phenylalanine (F) at codon 508 (ΔF508) on chromosome 7 is the main cause for 
CF, affecting 90% of patients. This mutation results in an abnormal folding of CFTR and a trafficking 
defect from the ER (Endoplasmic Reticulum) to the plasma membrane45. 
The predicted CFTR sequence contains 1,480 amino acids residues43 arranged in two membrane-
spanning domains (MSD), two nucleotide-binding domains (NBD) and one regulatory domain (R)46 
(Fig. 1.5). CFTR evolved from the ATP-binding cassette (ABC) transporters, sharing a high sequence 
and structure similarity with these proteins42. Activation of CFTR requires phosphorylation of serine 
residues in the R domain by the cAMP- dependent Protein Kinase A (PKA). ATP binding to the NBD 
domains and its subsequent hydrolysis allows the pore opening and provides enough energy to the 
transport of substances. Once the R domain is dephosphorylated by phosphatases CFTR returns to its 
closed status. Thus, the balance between kinase and phosphatase activity together with ATP levels are 
the main regulators of CFTR gating42,44,47. 
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Figure 0.5. Scheme of CFTR structure. CFTR is inserted in the plasma membrane and contains two MSD domains (MSD1, 
MSD2), two NBD domains (NBD1, NBD2) and one R domain with multiple phosphorylation sites. Retrieved and adapted 
from Farinha et.al.46. 
Regardless the continuous efforts in understanding CFTR at its functional and molecular level, CF 
remain a lethal disease. By attenuating symptoms, life expectancy has been significantly increased to 
around 37 years-old. However, chronic lung disease and resulting loss of pulmonary function is still a 
major uncontrolled problem, being responsible for 80% of mortality41. Nowadays, different therapy 
approaches are under development, either based on the identification of compounds that rescue the 
CFTR trafficking defect (correctors) or stimulators of channel activity (potentiators)45. 
1.3.2 CFTR, Cystic Fibrosis and Apoptosis 
As described before, apoptosis is a non-inflammatory fundamental process essential to the clearance 
of aged or harmed cells. Notably, CF disease is characterized by a defective apoptosis, a problem that 
may contribute to the ongoing inflammations. The involvement of CFTR in cell death has been studied 
over the years and, although some results are controversial, it seems clear that this Cl- channel is a pro-
apoptotic factor48. 
CFTR has been described as a regulator of the redox status in the airways, mediating the transport 
of GSH (Glutathione) to the extracellular space49. GSH is a major antioxidant, responsible for 
scavenging the ROS produced as a result of cellular metabolism50. Indeed, measurements in the lung 
epithelial lining fluid of CF patients revealed a lower content in GSH compared to healthy individuals51. 
Therefore, mutations in CFTR impair GSH efflux and leads to an increase of the oxidative stress in the 
airways52. 
On the other hand, as GSH is transported, the intracellular level of this antioxidant decreases. Hence, 
cells expressing wt CFTR are less capable to buffer high concentrations of ROS and have a higher 
susceptibility to apoptosis. Indeed, a relationship between CFTR, GSH efflux and apoptosis was found 
in mice proximal tubules where this protein may be responsible for AVD and caspase-3 activation53. In 
a different study HeLa cells were transfected with wt or ΔF508 CFTR and it was found an association 
among CFTR, GSH transport and Bax activation, a pro-apoptotic protein54. 
Intracellular acidification is an essential phenomenon during apoptosis, required for caspase 
activation and DNA cleavage. Interestingly, CFTR is known to secrete not only Cl-, but also bicarbonate, 
regulating the pH from intracellular compartments. Analysis of mucus collected from lungs of CF 
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patients revealed the presence of high molecular DNA, which contributes to the increased viscosity. One 
explanation for this observation may be related to the apoptosis dysfunction found in CF epithelial 
cells55. Studies in Chinese hamster lung fibroblasts and mouse mammary epithelial cells proved an 
association between DNA fragmentation and CFTR. Cells expressing ΔF508 CFTR have a higher 
intracellular pH, due to the lack of Cl- and bicarbonate transport. Thus, when these cells are exposed to 
an apoptotic stimulus, the intracellular pH prevents nuclear condensation and DNA degradation55,56. 
The apoptotic signaling cascade is complex, involving multiple molecules and signals. In this 
pathway ceramide acts as a messenger mediating the activation of apoptosis57. Ceramide intracellular 
level is regulated by a balance in the activity of two different enzymes: acid sphingomyelinase (Asm) 
and acid ceramidase (Ac), responsible for ceramide production and degradation, respectively57,58. Asm 
is triggered by Pseudomonas aeruginosa infection , leading to the increase of the ceramide content in 
lipid rafts59. Ceramide-enriched lipid rafts are required for pathogen elimination and apoptosis. 
However, in 2008 a study concluded that ceramide accumulation also facilitates inflammation, cell death 
and infections in CF60. A high level of ceramide in the respiratory tract of uninfected CFTR-deficient 
mice was found to be responsible for persistent inflammations and death of respiratory epithelial cells. 
When CFTR is mutated the intracellular vesicles have a higher pH, which leads to an imbalance of Asm 
and Ac activities and consequently to accumulation of ceramide in membrane lipid rafts. Therefore, by 
administrating acid sphingomyelinase inhibitors it is possible to stabilize ceramide levels and decrease 
inflammation61. 
1.4 INTERACTION BETWEEN ANO6 AND CFTR 
The concept that CFTR may interact or regulate other Cl- channels and transporters has been around 
for many years. Before the identification of CFTR, ORCC was thought to be the Cl- channel defective 
in Cystic Fibrosis22. Nowadays, it is known that CFTR and ORCC are independent channels that share 
functional relationships62. Interestingly, Martins et. al found that ANO6 is a component of the ORCC 
channel and may also be regulated by CFTR26. However, it is unknown if these ion channels interact 
directly or through other scaffold proteins63. Notably, ANO6 is responsible for ORCC activation during 
apoptosis, a phenomenon that becomes enhanced in the presence of CFTR. Martins et. al also reported 
a decrease of the cAMP-activated whole-cell conductance in airway epithelial cells expressing CFTR 
after knockdown of ANO6, which suggests a contribution of ANO6 to CFTR currents26. 
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1. OBJECTIVES 
The aim of the present work was to study the relationship between ANO6 and CFTR during ROS-
mediated apoptosis, using different in vitro systems. 
The first objective was to understand the impact of ROS in ANO6 activity. To achieve this, HEK293 
and HeLa cells were used either to overexpress ANO6 or downregulate the endogenous expression of 
this protein. In parallel experiments, B Lymphocytes immortalized from a Scott patient and a healthy 
control64 were useful to compare the presence and total absence of functional ANO6. The current 
properties of ANO6 after ROS induction were studied by patch clamp. Moreover, the phospholipid 
scramblase function of this protein was monitored by flow cytometry using Annexin V labeling. 
Because CFTR regulates the intracellular redox status49, the next question to address would be if 
CFTR-mediated GSH depletion and consequent intracellular ROS increase explain a possible 
relationship between these two ion channels. In order to accomplish this, co-expression studies were 
done in HEK293 cells and the same techniques were applied. Additionally, the CFBE cell line stably 
transfected with wt or ΔF508 CFTR was used as a system to look for the influence in ROS-mediated 
apoptosis of the most predominant CFTR mutation found in CF patients. 
The understanding of the role of ANO6 and CFTR in regulated cell death can be useful to get new 
insight about the apoptotic dysfunction that characterizes CF and eventually create new therapeutic 
approaches. 
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2. MATERIALS AND METHODS 
3.1 CELL CULTURE 
Cell lines were grown inside an incubator, at 37°C in a 5% CO2-95% air humidified water-saturated 
atmosphere. All cell culture was performed according to standard conditions, using sterile equipment. 
Every 2 to 5 days, cells were trypsinized (70-90% confluency) from 75 or 25 cm2 flasks (Greiner bio-
one - CELLSTAR®, Frickenhausen, Germany) and, if necessary, seeded in plastic plates (M&B Stricker 
Laborfachhandel GbR, Bernried, Germany) at the required density to preform experiments. 
3.1.1 Mammalian Cell Lines and Culture Conditions 
HEK293 (Human Embryonic Kidney 293)65 and HeLa66 (Henrietta Lacks Cervical Carcinoma) cell 
lines were cultured in Dulbecco's Modified Eagle Medium (DMEM; Life Technologies - gibco®, 
Karlsruhe, Germany), supplemented with 10% Fetal Bovine Serum (FBS; Life Technologies - gibco®, 
Karlsruhe, Germany). 
HeLa–Kyoto cells stably transfected with eYFP67 (Enhanced Yellow Fluorescent Protein) with three 
point mutations (H148Q, I152L, F46L) were cultured in MEM (Minimum Essential Medium), 
GlutaMAX™ (Life Technologies - gibco®, Karlsruhe, Germany), supplemented with 10% FBS, 1% 
Penicillin-Streptomycin (Pen Strep; Life Technologies - gibco®, Karlsruhe, Germany) and 200 µg/mL 
Hygromycin B (Promocell, Heidelberg, Germany). 
B Lymphocytes, isolated from a patient with Scott Syndrome and a control subject64, were cultured 
in Roswell Park Memorial Institute medium (RPMI; Life Technologies - gibco®, Karlsruhe, Germany), 
supplemented with 10% FBS, 1% Pen Strep and 5 mM Hepes Buffer Solution (Life Technologies - 
gibco®, Karlsruhe, Germany). 
CFBE cells68 (Cystic Fibrosis Bronchial Epithelial cells)  stably transfected with wt or ∆F508 CFTR 
were cultured in MEM, supplemented with 10% FBS and 2,5 µg/mL Puromycin (Life Technologies - 
gibco®, Karlsruhe, Germany). 
To trypsinize adherent cells from flasks (HEK293, HeLa, HeLa-Kyoto, CFBE), cultured medium 
was first removed by aspiration and cells were washed with Dulbecco’s Phosphate Buffered Saline 
(PBS; Life Technologies - gibco®, Karlsruhe, Germany), without Ca2+ and Mg2+. Trypsin (Life 
Technologies - gibco®, Karlsruhe, Germany) was added to culture flasks and incubated at 37°C, 5% 
CO2 for 5 min (HEK293, HeLa, HeLa-Kyotto) or 15 min (CFBE). To stop the trypsinization process, 
medium containing 10% FBS was added to cell suspension, which was then centrifuged at 20 000 rpm 
for 3 min. For B Lymphocytes, suspension cells were collected and centrifuged at 20 000 rpm for 5 min. 
In both cases, after the centrifugation step, supernatant was discarded and cells were resuspended in 
fresh culture medium. 
3.1.2 Transient Transfections 
All transient transfections were performed using Lipofectamine™3000 reagent (Invitrogen, 
Germany), according to manufacturer’s instructions. Lipofection is a particular method of transfection, 
where the genetic material is delivered to cells through a cationic lipid that forms liposomes and interacts 
with nucleic acid molecules (negatively charged). With lipofection it is possible to have a high uptake 
of the genetic material, allowing an easy overexpression of a protein of interest, using DNA, or a 
downregulation of a target gene, by siRNA (small interfering RNA)69,70. 
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HEK293 and HeLa cells were transfected with a pcDNA3.1 vector encoding for human ANO6. 
CFTR was transfected only in HEK293 cells, using a pIRES vector with the respective sequence coupled 
to a CD8 (Cluster of Differentiation 8) receptor, which was proved to be the available plasmid with the 
best transfection efficiency. In every experiment, an empty pcDNA3.1 vector (mock) served as a control 
and the same amount of plasmid was used in all transfections. When ANO6 and CFTR were co-
expressed in HEK293 cells, a ratio of 1:2 µg was applied. Co-transfection protocol was controlled by 
co-expressing the mock plasmid either with ANO6 or CFTR (using the same ratio). For patch clamp 
measurements, all transfections were done using a plasmid containing ANO6 or CFTR sequence linked 
to a CD8 receptor. Experiments were performed between 48h and 72h after transfections. All the cDNA 
used is described in the Appendices section (Appendix I – Table 8.1). 
ANO6 endogenous expression was downregulated in HEK293 and HeLa cells, using different 
siRNA’s (Invitrogen, Paisley, UK) and confirmed by Western Blot (WB). A negative control (Ambion®, 
Darmstadt, Germany) with no sequence similarity for human, mouse or rat gene sequences was used to 
control the effects of the siRNA delivery. Experiments and collection of protein for WB were done 
between 24h and 72h after transfection. 
3.1.3 Apoptosis Induction 
Tert-Butyl Hydroperoxide (tBHP, Sigma, Taufkirchen, Germany) was diluted in deionized filtered 
water to a final concentration of 100 mM. HEK293 cells were incubated with 100 µM tBHP in 
OptiMEM (Life Technologies - gibco®, Karlsruhe, Germany), a reduced serum medium (2% serum). 
CFBE cells were incubated with 100 µM tBHP diluted in MEM. Staurosporine (STS, Merck, Darmstadt, 
Germany) was dissolved in DMSO (dimethyl sulfoxide) to a final concentration of 1 mM. HEK293, 
HeLa and B lymphocytes were incubated with 1 µM STS diluted in OptiMEM, DMEM or RPMI, 
respectively. The appropriate volume of DMSO was added to non-treated controls. Hydrogen peroxide 
(H2O2, Riedel-de Haen, Seelze, Germany) was diluted in MEM to a final concentration of 900 µM and 
incubated in CFBE cells. Lyso-phosphatidylserine (Lyso-PS, Avanti Lipid, Alabama, U.S.A) was 
dissolved in chloroform to a final concentration of 10 mM. HEK293 cells were incubated with 10 µM 
Lyso-PS for 2h diluted in DMEM. The appropriate volume of chloroform was added to non-treated 
controls. All compounds were incubated for the indicated periods of time at 37°C, 5% CO2, except 
Ionomycin (Iono, Biomol, Hamburg, Germany) which was added to cells after cell detachment during 
experiments to a final concentration of 1, 5 or 10 µM. Inhibitors were purchased from Sigma 
(Taufkirchen, Germany) and pre-incubated for at least 30 min at 37°C, 5% CO2.  
3.2 PROTEIN ANALYSIS – WESTERN BLOT 
ANO6 expression was downregulated in HEK293 and HeLa cells (see section 3.1.2 – 3.1.2 
Transient Transfections) and confirmed by WB. Additionally, ANO6 endogenous expression was 
detected in CFBE cells. In order to accomplish this, protein was collected from cells and kept in a lysis 
buffer (mM: 50 Tris-HCl, 150 NaCl, 50 Tris, 100 DTT, 0.5% NP-40, 1% protease inhibitor cocktail) - 
Roche, Germany. Then, protein content was separated in an 8,5% SDS-PAGE Polyacrylamide gel and 
separated proteins were transferred to a PVDF (Polyvinylidene fluoride) membrane (GE Healthcare 
Europe GmbH, Munich, Germany). To detect ANO6, the membrane was incubated with a primary 
antibody (rabbit antihuman ANO6 – David Technology, Germany) overnight at 4°C, using a dilution 
factor of 1:500 – 1:1000. Proteins were visualized using a horseradish peroxidase (HRP) - conjugated 
goat antirabit secondary antibody (Dilution Factor of 1:10000) and ECL Detection Kit (GE, Healthcare, 
Munich, Germany). Protein bands were detected using a FujiFilm LAS-3000 (FujiFilm, Tokyo, Japan). 
Experiments were kindly performed by Podchanart Wanitchakool. 
Materials and Methods 
 
11 
 
3.3 FLUORESCENCE MICROSCOPY 
3.3.1 ROS Detection 
Intracellular ROS detection is possible using fluorescence assays. H2DCFDA (2',7'-
dichlorodihydrofluorescein diacetate, Molecular Probes, Invitrogen, Germany) is a non-fluorescent 
molecule able to cross plasma membranes. Once in the cytosol, this probe is deacetylated by intracellular 
esterases and, as a consequence, trapped inside the cell. In the presence of ROS, the deacetylated form 
is oxidized to a highly fluorescent form, DCF - 2',7'-dichlorofluorescein (Fig. 3.1). Thus, the 
fluorescence intensity is an index of intracellular ROS level. 
 
Figure 2.1. Mechanism of ROS detection by H2DCFDA. H2DCFDA is able to cross the plasma membrane. Once inside the 
cell, the probe is deacetylated by esterases, ensuring probe retention in the cytosol. In the presence of ROS, the non-fluorescent 
molecule is oxidized to DCF, which is highly fluorescent, allowing intracellular ROS detection. 
Due to easy oxidation, H2DCFDA was dissolved shortly before experiments in DMSO to a final 
concentration of 10 mM. To detect ROS, HEK293 and HeLa cells were seeded in 18 mm 
collagen/fibronectin-coated glass cover-slips overnight. Cells were loaded with a solution of 10 µM of 
H2DCFDA in PBS with Ca2+ and Mg2+ (Life Technologies - gibco®, Karlsruhe, Germany) for 30 min at 
37°C, 5% CO2. After loading, the probe was washed 2 times with PBS and the ROS inducer was added 
to cells (tBHP or STS) for the desired period of time. Fluorescence increase was detected with an 
ApoTome Axiovert 200M fluorescent microscope (Zeiss, Germany), using an excitation wavelength of 
493 nm and emission of 520 nm. 
Alternatively, ROS was detected using a fluorogenic cytosolic sensor, MAK142 (Taufkirchen, 
Germany), which becomes fluorescent in the presence of superoxide and hydroxyl radicals. In this case, 
HEK293 cells were plated in 18 mm collagen/fibronectin-coated glass coverslips overnight and treated 
with STS. After apoptosis induction, MAK142 was added to cells and fluorescence was monitored. 
Fluorescence increase was detected with the same microscope, using an excitation wavelength of 646 
nm and emission of 654 nm. 
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3.4 FLOW CYTOMETRY – APOPTOSIS DETECTION 
Flow cytometry is a laser-based technology that allows single cell measurements. It is commonly 
used to get information about fluorescence of a pre-labeled population of cells. Once samples are 
injected into the flow cytometer, molecules are excited by a light source and fluorescence of single cells 
is detected. This is a multifunctional technique, which also allows the analysis of physical properties, 
such as cell size or granularity, two parameters given by forward (FSC) and side (SSC) scatter, 
respectively. To study regulated cell death in the present work, a four optical filter BD Accuri™ C6 
Cytometer (BD Biosciences, Heidelberg, Germany) was used. 
3.4.1 Caspase-3 Activity Measurements 
NucView™ 488 Caspase-3 substrate (Biotium, Fremont, USA) is a fluorogenic sensor used for the 
detection of caspase-3 activity. It is formed by a DNA marker linked to a peptide sequence (DEVD). 
Once this substrate crosses the cell membrane, the DEVD sequence is cleaved by caspase-3 and the 
DNA dye is free to stain the nucleus (Fig. 3.2). Therefore, by measuring the fluorescence intensity of 
the DNA marker it is possible to monitor caspase-3 activity. 
 
Figure 2.2. Mechanism of Caspase-3 activity detection by NucView™ 488 Caspase-3 substrate. Caspase-3 substrate is 
formed by a peptide sequence (DEVD) linked to a DNA fluorogenic sensor. Once inside the cell, the substrate is cleaved at the 
DEVD sequence by caspase-3, releasing the DNA dye, which is then free to stain the nucleus. 
In order to detect caspase-3 activation after ROS induction, HEK293 and HeLa cells were seeded 
overnight and incubated as desired for the indicated periods of time. Following treatment, the media was 
collected and cells were washed with PBS. After, adherent cells were detached with accutase (Capricorn 
Scientific GmbH, Ebsdorfergrund, Germany), incubated for 3 to 5 min, at 37°C, 5% CO2. Then, the 
reaction was stopped with DMEM, supplemented with 10% FBS and suspension cells were centrifuged 
2 times for 10 min (1500 rpm, 4°C). Cells were resuspended in a solution of caspase-3 substrate diluted 
in PBS (2.5 µL substrate in 100 µL of PBS / sample) and incubated for 30 min at room temperature, 
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protected from light. Before measurements, DNA labeling was stopped with PBS (300 µL/ sample) and 
fluorescence was detected by flow cytometry, using filter 1 (excitation - 488nm; emission - 530 nm). 
3.4.2 Annexin V and 7-AAD Labeling 
As described in the Introduction chapter, exposure of phosphatidylserine is one of the apoptosis 
hallmarks. Annexin V (Annx V) belongs to the annexin family of proteins, having the particularity of 
being able to bind specifically to PS in the presence of millimolar concentrations of Ca2+ 71. Thus, by 
conjugating Annx V with the fluorophore FITC (Fluorescein isothiocyanate) it became possible to 
monitor PS exposure by flow cytometry. 
Annx V labeling is usually coupled to 7-AAD (7-Aminoactinomycin D), a membrane impermeable 
DNA marker with high affinity for G-C regions72. By combining these two dyes it is possible to 
distinguish between early/late apoptosis and necrosis: PS exposure is an early event in apoptosis, 
whereas changes in the plasma membrane permeability are characteristic from late apoptotic stages or 
necrosis. Therefore, fluorescence intensity in an early apoptotic cell will be positive for Annx V and 
negative for 7-AAD, whereas a late apoptotic or necrotic cell will be positive for both dyes. 
By flow cytometry it is possible to measure Annx V and 7-AAD fluorescence intensity and conclude 
about cell viability. Both parameters can be compared in a 4-quadrants plot, representing either positivity 
or negativity for Annx V (x axis) and/or 7-AAD (y axis). The quadrants setting is defined with viable 
cells which maintain the plasma membrane asymmetry and integrity and thus are negative for both dyes 
(Fig. 3.3). 
 
Figure 2.3. Schematic representation of dual staining with Annx V and 7-AAD. In a viable cell the plasma membrane is 
intact and asymmetric, therefore Annx V and 7-AAD fluorescence intensity is negative (lower-left quadrant). In an early 
apoptotic cell PS moves from the inner to the outer membrane leaflet, which allows Annx V binding (lower-right quadrant). 
Once cells enter in late apoptosis/ necrosis, the plasma membrane permeability is compromised and 7-AAD can enter the cell. 
Thus, cells become positive for both markers (upper-right quadrant). 
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In order to detect membrane modifications during apoptosis, cells were treated according to the 
previous section and media was collected after the indicated time points. Adherent cells (HEK293, HeLa 
and CFBE cells) were then washed with PBS and detached with accutase for 3-15 min at 37°C, 5% CO2. 
After cell detachment, accutase reaction was stopped with DMEM/MEM, supplemented with 10% FBS. 
Suspension cells (B Lymphocytes) were collected after apoptosis induction. In both cases, cells were 
centrifuged 2 times for 10 min at 1 500 rpm (4°C). Following centrifugations, each sample was incubated 
in a solution of 5 µL Annx V and 2,5 µL 7-AAD, diluted in 100 µL Annexin V-binding buffer 
(BioLegend, Fell, Germany) for 10 min at room temperature, protected from light. After labeling, the 
reaction was stopped with PBS (400 µL/sample). For each experiment, 10 000 events were collected 
and fluorescence was detected by flow cytometry, using filter 1 for Annx V (excitation – 488 nm; 
emission - 530 nm) and filter 3 for 7-AAD (excitation – 488 nm; emission – 670 nm). The emission 
spectra of Annx V and 7-AAD overlap at some extent. Therefore, to avoid a false positive, the signal 
was always compensated using a pre-determined value. 
3.5 HOLOGRAPHIC MICROSCOPY 
Holographic microscopy is a non-invasive label-free method used to monitor adherent cells. The 
HoloMonitor™ M2 (Phase Holographic Imaging AB, Lund, Sweden) is a microscope that uses digital 
holography to acquire and quantify information about cell shape, volume, area, confluence and 
thickness73. For this purpose, the microscope is placed inside an incubator at 37C with a humidified 
atmosphere saturated with 5% CO2, where cells can be monitored over time. 
This method was useful to follow cellular morphology after apoptosis induction in HEK293 cells. 
In order to accomplish this, cells were seeded one or two days before experiments in 
collagen/fibronectin-coated petri-dishes and monitored for the desired period of time in the presence or 
absence of ROS inducer.  
3.6 CONDUCTANCE MEASUREMENTS 
3.6.1 YFP Fluorescence Quenching Assay 
The Yellow Fluorescent Protein (YFP) is particularly interesting due to its sensibility to surrounding 
halide concentrations. This sensor has a cavity formed by a specific binding site for halide ions, such as 
iodide (I-) or chloride (Cl-)74. Binding of anions to this cavity leads to a decrease in the YFP fluorescence 
intensity over the time (quenching). 
HeLa-Kyoto cells stably expressing eYFP were used to measure anion conductance during 
apoptosis. In this cell line the YFP sequence is modified with three different point mutations (H148Q, 
I152L and F46L), which enhance the halide affinity74. Briefly, cells were seeded in collagen/fibronectin-
coated transparent 96 well-plates (Thermo Fisher Scientific, Darmstadt, Germany) and incubated at 
37°C, 5% CO2 with STS diluted in Ringer -40 mM Cl- solution (mM: 105 NaCl; 0,4 KH2PO4; 1,6 
K2HPO4.3H2O; 5 Glucose; 1 MgCl2.6H2O; 1,3 Ca-Gluconate.1H2O; 40 Na-Gluconate; pH 7.4). After 
incubation, YFP fluorescence was measured at 37°C by a Microplate Reader (BMG LABTECH, 
Offenburg, Germany; excitation – 485 nm; emission – 520 nm) each second, during 30 seconds. 
Following this, a Ringer solution was injected containing NaI to a final concentration of 20 mM (mM: 
105 NaCl; 0,4 KH2PO4; 1,6 K2HPO4.3H2O; 5 Glucose; 1 MgCl2.6H2O; 1,3 Ca-Gluconate.1H2O; 40 NaI; 
pH 7.4) and fluorescence was measured for 1 minute, every second. 
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Thus, by using this method it is possible to study channel activity: when ion channels are closed, 
injection of I- does not interfere with YFP fluorescent signal; however, once ion channels are opened, I- 
is able to cross the plasma membrane and bind to YFP, quenching its fluorescence (Fig. 3.4).  
 
Figure 2.4. YFP Fluorescence Quenching by Iodide (I-). When ion channels are closed, I- cannot cross the plasma membrane 
and YFP remains fluorescent. However, if ion channels are opened, the I- is able to permeate through the channel pore and bind 
to YFP cavity, quenching the fluorescent signal. 
3.6.2 Patch Clamp 
Patch clamp allowed a sensitive measurement of the basal current activated by ROS. In order to 
accomplish this, HEK293 and HeLa cells were grown in collagen/fibronectin - coated 18 mm glass 
coverslips and transfected according to section 3.1.2 Transient Transfections, in the presence of the CD8 
receptor. After transfection, HEK293 and HeLa cells were treated with tBHP or STS at 37°C, 5% CO2 
for the desired period of time. Following exposure to ROS, cells were incubated 1-2 min with Dynabeads 
CD8 (Invitrogen, Germany), a step that allowed the identification of the transfected cells.  
Coverslips were then mounted in a chamber on the stage of an inverted microscope (IM35, Zeiss, 
Germany) where whole-cell current was measured. The bath was perfused continuously at 37°C with 
Ringer solution (mM: 145 NaCl; 0,4 KH2PO4; 1,6 K2HPO4.3H2O; 5 Glucose; 1 MgCl2.6H2O; 1,3 Ca-
Gluconate.1H2O; pH 7.4). In order to prove that the detected current results from Cl- movement, Ringer 
was replaced with a 5 mM Cl- solution (mM: 5 NaCl; 0,4 KH2PO4; 1,6 K2HPO4. 3H2O; 5 Glucose; 1 
MgCl2.6H2O; 8 Ca-Gluconate.1H2O, 140 Na-Gluconate; pH 7.4).  Regarding tBHP experiments, the 
ROS inducer was diluted in the bath solution to ensure the presence of the compound during 
measurements. The patch pipette was filled with a solution containing 95 mM K-Gluconate, 30 mM 
KCl, 1.2 mM NaH2PO4.H2O, 4.8 mM Na2HPO4.2H2O, 5 mM Glucose, 2.38 mM MgCl2.6H2O, 1 mM 
EGTA (Ethylene Glycol Tetraacetic Acid) and 0.726 mM Ca-Gluconate.1H2O, with freshly added 3 
mM ATP and pH adjusted to 7.2. 
Materials and Methods 
16 
 
Membrane voltage was clamped in steps of 20 mV from -100 to +100 mV from a holding voltage 
of -100 mV. Currents and voltages were recorded using a patch clamp amplifier EPC 9 and PULSE 
software (HEKA, Lambrecht, Germany), as well as a Chart software (AD-Instruments, Spechbach, 
Germany).  
Experiments were kindly performed by Lalida Sirianant and Jiraporn Ousingsawat. 
3.7 CALCIUM SIGNALING MEASUREMENTS – FURA-2 AM  
HEK293 and HeLa cells were seeded in collagen/fibronectin 18 mm coated glass coverslips and 
treated with tBHP and/or STS (see section 3.1.3 – Apoptosis Induction). Following ROS induction, cells 
were loaded with 2 µM Fura-2 AM (Molecular Probes, Invitrogen, Germany) diluted in ringer solution, 
in the presence of 0.02% Pluronic, (Molecular Probes, Invitrogen, Germany) for 1h at room temperature. 
After loading, the coverslips were mounted in a cell chamber and perfused continuously with ringer 
solution. 
Fura-2 AM is a membrane-permeable calcium indicator formed by an ester group (AM- 
acetoxymethyl). When loaded into cells, the AM group is cleaved by esterases, allowing retention of the 
sensor in the cytosol. 
In order to measure the intracellular concentration of Ca2+ ([Ca2+]i), Fura-2AM fluorescence was 
detected using an inverted microscope Axiovert S100 (Zeiss, Germany) Flua 40x/1.30 oil objective 
(Zeiss, Germany) and a high speed polychromator system (VisiChrome, Visitron Systems, Germany), 
at an excitation wavelength of 340/380 nm, and emission 470-550 nm using a CCD-camera (CoolSnap 
HQ, Visitron Systems, Germany). 
The software package Meta-Fluor (Universal imaging, USA) allowed imaging acquisition and data 
analysis. Intracellular Ca2+ was calculated according to the 340/380 nm fluorescence ratio, after 
background subtraction and calibration75. 
Experiments were kindly performed by Ana Fonseca. 
3.8 STATISTICAL ANALYSIS 
For Statistical Analysis, student’s t-test (paired and unpaired samples) and analysis of variance 
(ANOVA) were used as suitable. Values were accepted as significant if p-value < 0.05.
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3. RESULTS 
4.1 ANO6 IS ACTIVATED BY ROS 
The first goal of this study was to determine if ANO6 is activated by ROS. To accomplish this, 
overexpression studies were done in HEK293 or HeLa cells and apoptosis was induced either by tBHP 
or STS. In parallel experiments ANO6 endogenous expression was downregulated by siRNA and 
confirmed by Western Blot in both cell lines.  
4.1.2 ANO6 plays a role in tBHP-induced apoptosis of HEK293 cells  
Tert-butyl hydroperoxide or tBHP is an oxidative stress inducer commonly used in different 
biological systems76, being a good tool to study the influence of ROS in ANO6 activity. In order to 
identify the time frame required for ROS increase in HEK293 cells, H2DCFDA fluorescence was 
monitored after incubation with 100 µM tBHP for 30 min, 1h and 2h. By this assay it was possible to 
conclude that 30 min of exposure is sufficient to trigger ROS production to a detectable level, compared 
to negative control. Moreover, this effect persists at least for 2h upon incubation, when a significant 
difference in cell morphology can be still observed in the correspondent DIC (Differential Interference 
Contrast) picture (Fig. 4.1 A). 
As previously outlined, one of the apoptotic hallmarks is cell shrinkage1,11, which contrasts to 
swelling observed during necrosis8. These two processes can be activated by the same physiological and 
pathological stimuli, depending on the degree of exposure1. Indeed, in rat hepatocytes, tBHP is described 
to induce both necrosis and apoptosis76. Because the present study is focused on regulated cell death, 
the identification of the mechanism induced by 100 µM tBHP in HEK293 cells was mandatory. To 
accomplish this, cell volume was monitored by holographic microscopy during 3h of exposure to the 
ROS inducer. These measurements indicated that cells start to shrink substantially after 1h30min of 
incubation with tBHP (Fig. 4.1 B). 
A relationship between caspase activation and shrinkage is well described. In fact, it is believed that 
these proteins mediate the morphological changes seen in apoptotic cells1. Interestingly, in agreement 
with these statements, a 60% increase in caspase-3 activity was detected after 2h of exposure to tBHP, 
a simultaneous phenomenon to volume reduction. This increase is expressed as a shift of the 
fluorescence peak of caspase-3 substrate, compared to control cells (Fig. 4.1 C, D).  
GSH is the reduced form of glutathione and the most prevalent thiol present in cells, responsible for 
the protection of DNA, proteins and lipids. When cells are exposed to ROS, GSH is oxidized or 
transported to the extracellular space, being no longer available to play its role50. Therefore, 
supplementation of GSH is expected to rescue cells form ROS-induced apoptosis. This hypothesis was 
tested using a membrane permeable synthetic derivative of GSH, Glutathione reduced Ethyl Ester 
(GSHEE). It was observed that pre-incubation of HEK293 cells with 10 mM GSHEE for 2h resulted in 
a 3-fold inhibition of tBHP-induced caspase-3 activity (Fig. 4.1 C, D). 
In conclusion, tBHP increases intracellular ROS which is likely mediating cell shrinkage and 
caspase-3 activation. For this reason, this compound can be used as a tool to study ANO6 involvement 
in ROS-mediated apoptosis of HEK293 cells. Additionally, Annx V and 7-AAD flow cytometry 
measurements revealed that tBHP-induced cell death can be strongly inhibited by Idebenone (Ide), a 
synthetic analog of the coenzyme Q10/ubiquinone (Appendix II – Fig. 8.1). Ubiquinone belongs to the 
mitochondrial respiratory chain, participating in the ATP synthesis by transporting electrons77. As 
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previously described, during apoptosis this process is stopped due to mitochondrial permeabilization12. 
Therefore, administration of Idebenone restores partially the ATP synthesis and inhibits apoptosis.  
 
Figure 3.1. ROS production, cell shrinkage and caspase-3 activation by tBHP in HEK293 cells. A) Representative images 
from three different experiments showing the over-time effect of tBHP (100 µM) in ROS production monitored by H2DCFDA 
fluorescence (30 min, 1h and 2h).  Bar indicates 20 µm. B) Volume (µm3) measurements of control and tBHP treated cells (100 
µM). Cell shrinkage is clear after 1h30min of exposure to tBHP. C) Caspase-3 activity induced by treatment with 100 µM 
tBHP for 2h (green), compared to non-treated cells (black). Inhibition of caspase-3 activation by GSH supplementation 
(GSHEE 10 mM; pre-incubation for 2h). Each peak corresponds to one representative experiment from a total of 3-5. D) 
Summary of caspase-3 measurements shown in C. (Values are mean ± SEM; #/# unpaired t-test to control, # unpaired t-test to 
tBHP treated group, p- value < 0.05; n = number of cells, from 3 different experiments for volume measurements, n = number 
of experiments for caspase-3 activity measurements). 
ANO6 is identified as a Ca2+-activated Cl- channel19,20 and a non-selective cation channel18. 
Therefore, to understand the ROS effect in ANO6 activity, the function of this protein was firstly studied 
in terms of current. Whole-cell currents were measured by patch clamp in HEK293 cells transfected 
with mock or ANO6 after incubation with 100 µM tBHP for 30 min, an exposure time sufficient to 
increase the intracellular level of ROS (Fig. 4.1 A). Cells overexpressing ANO6 had a significant higher 
current in the presence of tBHP, compared to mock and non-treated cells. The endogenous expression 
of ANO6 in this cell line is relatively low (Appendix III – Fig. 8.2) which may explain why tBHP did 
not activate a basal conductance in mock cells compared to control (Fig. 4.2 A, B, C). 
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In order to know if the detected current results from Cl- movement, the Ringer bath solution was 
replaced with another containing a reduced concentration of Cl- (5 mM). By applying this protocol, it 
was expected an inhibition of the Cl- current, due to a shift in the concentration gradient. As predicted, 
the tBHP-induced conductance of ANO6 overexpressing cells was reduced in the presence of the 5 mM 
Cl-. However, because ANO6 is poor selective for Cl- ions, being described also as a non-selective cation 
channel27, the current was not completely abolished (Fig. 4.2 A, B, D). 
 
Figure 3.2. tBHP activates an ANO6-dependent Cl- conductance. A) Current overlays from tBHP treated cells (100 µM; 
30 min) and inhibition by 5Cl-. Overexpression of ANO6 increases tBHP-induced current compared to mock cells. B) 
Corresponding current-voltage (I/V) relationships from experiments shown in A. C) Respective current densities from 
experiments shown in A. D) Summary of inhibition of tBHP- induced current by 5Cl- for mock and ANO6 transfected cells. 
(Values are mean ± SEM; # unpaired t-test to control, * paired t-test to tBHP treated cells, p-value < 0.05; n = number of cells). 
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In addition to an ANO6-dependent Cl- conductance, this protein was also found to contribute to 
tBHP-induced scrambling. This was observed when HEK293 cells were transfected with mock or 
ANO6, treated with tBHP and labeled with Annx V and 7-AAD. Flow cytometry measurements revealed 
a clear difference between mock and ANO6 overexpressing cells in Annx V and Annx V + 7-AAD 
positive cells, after 3h30 of exposure to tBHP. Remarkably, overexpression of ANO6 by itself and low 
serum conditions were enough to increase significantly this positivity, compared to mock control group 
(Fig. 4.3 A, B). This observation can be related to a study of Schenk et. al, where ANO6 was found to 
regulate the baseline PS exposure and cell viability of HEK293 cells78. 
 
Figure 3.3. ANO6 is activated by tBHP as a phospholipid scramblase. A) Representative original dot-plots of flow 
cytometry analysis from mock and ANO6 transfected HEK293 cells. B) Summary of Annx V and Annx V + 7-AAD positivity 
after exposure to 100 µM tBHP for 3h30. Treatment with tBHP leads to a significant increase in Annx V / Annx V + 7-AAD 
positive cells in mock and ANO6 groups, compared to respective controls. Cells overexpressing ANO6 undergo apoptosis 
faster when exposed to oxidative stress. C) Representative FSC histograms of experiments shown in A. ANO6 overexpression 
results in a strong shrinkage in the presence of tBHP. (Values are mean ± SEM; # unpaired t-test to control, # unpaired t-test 
to mock treated cells, # unpaired t-test to mock non-treated cells, p- value < 0.05; n = number of experiments). 
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Additionally, by flow cytometry was also possible to conclude about cell size in the presence and 
absence of tBHP – whereas, mock cells show just a small shift in the FSC histogram compared to control, 
ANO6 overexpression resulted in a strong cell shrinkage induced by tBHP (Fig. 4.3 C). 
It is interesting to note the different time points between detection of ANO6 Cl- conductance and 
scrambling. While a Cl- conductance was observed only after 30 min of exposure to tBHP (Fig. 4.2), 
the same conditions were not enough to induce scrambling (data not shown).  
In order to know if ANO6 is essential for PS exposure triggered by ROS, the endogenous expression 
of this protein was silenced in HEK293 cells by siRNA (Appendix III – Fig. 8.2) and the same protocol 
was applied. However, transfection with siRNA likely resulted in off target effects, enhancing cell death 
induced by tBHP compared to scrambled cells (Appendix IV – Fig. 8.3), which can be explained by 
upregulation of other proteins involved in the apoptotic pathway. 
4.1.3 ANO6 contribution to STS-mediated apoptosis of HEK293 and HeLa cells  
Staurosporine is a cell permeable alkaloid isolated from the bacterium Streptomyces staurosporeus, 
commonly used to study apoptosis79. Aside from functioning as a non-specific protein kinase inhibitor80, 
this compound is also described to increase the intracellular level of ROS81. Hence, like tBHP, STS can 
be used as a tool to study the possible effect of ROS in ANO6 activity. Indeed, intracellular ROS 
production in HEK293 cells was detected after incubation with 1 µM STS for 24h, using the fluorogenic 
sensor MAK142 (Fig. 4.4 A). In agreement with results from the previous section, overexpression of 
ANO6 and exposure to STS led to an increase of the Annx V and Annx V + 7-AAD positive cells (Fig. 
4.4 B, C). 
 
Figure 3.4. ANO6 contribution to PS exposure induced by the ROS-producer STS. A) Representative images from three 
different experiments showing ROS production after treatment with 1 µM STS for 24h, monitored with MAK142 fluorescence. 
Bar indicates 20 µm. B) Representative original dot-plots of flow cytometry analysis from mock and ANO6 transfected 
HEK293 cells in the presence and absence of 1 µM STS for 24h. C) Summary of Annx V and Annx V + 7-AAD positivity of 
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experiments shown in B. Treatment with STS and ANO6 overexpression leads to a significant increase in Annx V and Annx 
V + 7-AAD positive cells, compared to mock. (Values are mean ± SEM; # unpaired t-test to control, # unpaired t-test to mock 
treated cells, p- value < 0.05; n = number of experiments). 
After observing that ANO6 is involved in ROS-mediated apoptosis of HEK293 cells, it was 
interesting to look if this is also true for another cell line. With this purpose, HeLa cells were incubated 
with 1 µM STS for 5h. As expected, exposure to STS led to ROS production and caspase-3 activation 
(Fig. 4.5 A, B, C). Also, overexpression of ANO6 enhanced significantly the Annx V positivity after 
incubation with STS, compared to mock (Fig. 4.5 D, E). Surprisingly, downregulation of endogenous 
expression by siRNA (Appendix III – Fig. 8.2) did not reduce cell death (Fig. 4.6). 
 
Figure 3.5. STS leads to ROS increase and caspase-3 activation, mediating PS exposure enhanced by overexpressed 
ANO6 in HeLa cells A) Representative images from three different experiments showing ROS production by 1 µM STS 
monitored with H2DCFDA fluorescence (5h incubation). Bar indicates 20 µm. B) Representative original dot-plots of flow 
cytometry analysis from mock and ANO6 transfected HeLa cells in the presence and absence of 1 µM STS for 5h. C) Summary 
of Annx V positivity of experiments shown in B. ANO6 overexpression results in an increase of Annx V positive cells after 
exposure to STS. (Values are mean ± SEM; # unpaired t-test to control, # unpaired t-test to mock treated cells, p-value < 0.05; 
n = number of experiments). 
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Figure 3.6. Downregulation of ANO6 in HeLa cells does not inhibit Annx V positivity induced by STS. A) Representative 
original dot-plots of flow cytometry analysis from scrambled and siANO6 transfected HeLa cells in the presence or absence of 
STS for 5h. B) Summary of Annx V positivity of experiments shown in A. STS induces Annx V positivity independently of 
ANO6 expression level. (Values are mean ± SEM; # unpaired t-test to control, p-value < 0.05; n = number of experiments).  
ANO6 contribution to ROS-mediated apoptosis of HeLa cells was also studied in terms of current. 
First, by using the YFP-quenching assay, it was possible to detect an anion conductance activated by 
STS in HeLa-YFP cells (Fig. 4.7 A, B). This conductance is also observed by patch clamp and can be 
inhibited by downregulation of ANO6 and replacement with a 5 mM Cl- solution (Fig. 4.7 C, D, E).  
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Figure 3.7. STS activates ANO6 currents in HeLa cells.  A) YFP fluorescence measurements of HeLa-YFP cells in the 
absence and presence of 20 mM I- ( ). Activation of an anion conductance after exposure to 1 µM STS for 5h, indicated by I- 
efflux. B) Summary of I- uptake experiments shown in A. C) Overlay of whole-cell currents in HeLa cells, showing an 
activation of a STS-induced Cl- current, reduced by ANO6 silencing. D) Current-voltage (I/V) curves of experiments shown in 
B. Reduction of extracellular Cl- concentration results in a clear inhibition of baseline current detected after incubation with 1 
µM STS for 3h-4h. E) Summary of delta current density at + 100 mV after current inhibition by 5Cl- solution. (Values are 
mean ± SEM; # unpaired t-test to control p < 0.05, # unpaired t-test to mock treated cells, * paired t-test to tBHP treated, p-
value < 0.05; n = number of experiments). 
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4.2 CFTR ENHANCES ANO6 EFFECT DURING ROS-MEDIATED APOPTOSIS 
The next step of this project was focused on CFTR and the possible interaction of this protein with 
ANO6. As described before, CFTR is a main regulator of the intracellular redox status, transporting 
GSH to the extracellular space49. Moreover, a functional relationship between this channel and ANO6 
is also described26. Thus, it is hypothesized that CFTR-mediated cytosolic ROS increase may lead to 
ANO6 activation. If this is true, the presence of both proteins should enhance cell death under oxidative 
stress conditions. 
To address this question, HEK293 cells were co-transfected with ANO6 and CFTR and incubated 
with 1 µM STS for 24h. As a control, cells were either transfected with mock, ANO6 or CFTR. Like 
expected, single expression of ANO6 resulted in a significant increase of Annx V positive cells in the 
presence of STS, compared to control and mock treated cells. Notably, the same was detected for CFTR 
single transfection, which is in agreement with the function of this protein as a pro-apoptotic factor. Co-
expression of both proteins increased by a two-fold factor the Annx V positivity, compared to single 
expression of ANO6 and CFTR. Surprisingly, the presence of both proteins was sufficient to trigger cell 
death under control conditions to a significant level, evidenced by Annx V and 7-AAD positivity (Fig. 
4.8).  
 
Figure 3.8. CFTR enhances ANO6 contribution to apoptosis induced by STS in HEK293 cells. A) Representative original 
dot-plots of flow cytometry analysis from cells transfected with mock, ANO6, CFTR or ANO6 and CFTR in the presence or 
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absence of 1 µM STS for 24h.  B) Summary of Annx V and Annx V + 7-AAD positivity of experiments shown in A. In each 
group incubation with STS results in a significant increase of Annx V positive cells. Overexpression of ANO6 or CFTR 
augments this effect. Co-expression of both proteins enhances ANO6 and CFTR contribution to apoptosis. (Values are mean 
 SEM; # unpaired t-test to control, # unpaired t-test to mock treated group, * One-way ANOVA indicates significant difference 
compared to single expression, p-value < 0.05; n = number of experiments). 
The finding that ANO6 and CFTR cooperate in PS exposure during STS-induced cell death led to 
wonder if the same is true in terms of current activation. Therefore, single and co-expressed cells were 
measured by patch clamp after incubation with 1 µM STS for 6-8h. In agreement with flow cytometry 
data, overexpression of ANO6 or CFTR led to a significant increase in the basal current activated by 
STS, an effect strongly enhanced by the co-expression of both proteins. In the four studied groups 
(mock, ANO6, CFTR and ANO6 + CFTR), STS-induced current was inhibited by replacement with 5 
mM Cl- solution in the extracellular space, showing that the whole-cell conductance is partially formed 
by Cl- ions (Fig. 4.9).    
 
Figure 3.9. Enhanced apoptotic whole-cell Cl- currents in cells expressing ANO6, CFTR and ANO6 + CFTR. A) Current 
overlays from STS-treated HEK293 cells (1 µM 6h-8h) and inhibition by 5Cl-. Single expression of ANO6 or CFTR increases 
STS-induced compared to mock cells. Co-expression of both proteins enhances ANO6 and CFTR effect. B) Corresponding 
current-voltage relationships (I/V) from experiments shown in A. C) Respective current densities from experiments shown in 
A. D) Delta of corrected current density at +100 mV after Cl- replacement.  (Values are mean  SEM; * paired t-test to STS 
treated cells, # significant difference to indicated groups by unpaired t-test, a,b indicates significant difference calculated by 
one-way ANOVA to mock and ANO6 respectively, p-value < 0.05; n = number of cells). 
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4.2.1 ΔF508 CFTR mutation partially rescues cells from apoptosis 
The earlier experiments preformed in HEK293 cells demonstrated that both ANO6 and CFTR 
contribute to apoptosis, having a possible functional interaction when co-expressed (Fig. 4.8, 4.9). 
CFBE cells stably expressing wt or F508 CFTR were chosen as an in vitro system to study CFTR 
function and approach the results to a clinical significance.  
The first question was related to CFTR role during cell death and the impact of the trafficking 
mutation (ΔF508) in this process. With this purpose, CFBE cells (wt and ΔF508 CFTR) were exposed 
to oxidative stress and their susceptibility to cell death was evaluated. Simultaneous incubation of both 
cell lines with 100 µM tBHP for 24h led to a substantially difference in the Annx V and Annx V + 7-
AAD positive cells. While at the same time-point CFBE wt CFTR cells were in a late apoptotic stage – 
Annx V + 7-AAD positive – cells expressing the mutant CFTR form were still in the early steps – Annx 
V positive – (Fig. 4.10 A, B). It was also observed a considerable difference in the size of the two cell 
lines after exposure to tBHP – CFBE wt CFTR cells showed a significant shrinkage compared to ΔF508 
CFTR cells which had similar dimensions to control (Fig. 4.10 C). 
 
Figure 3.10. Effect of CFTR in tBHP-induced cell death. A) Representative original dot-plots of flow cytometry analysis 
from CFBE wt and F508 CFTR cells in the absence or presence of 100 µM tBHP for 24h. B) Summary of Annx V and Annx 
V + 7-AAD positivity of experiments shown in A. C) FSC histograms of experiments shown in A. Expression of wt CFTR 
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significantly enhances tBHP-mediated cell death, compared to F508 CFTR cells. (Values are mean  SEM; # unpaired t-test 
to control, # unpaired t-test to CFBE wt CFTR treated group, p-value < 0.05; n = number of experiments). 
Additional experiments were also performed using another ROS inducer, H2O2, and the same 
observations were taken. However, an over-time flow cytometry study revealed that hydrogen peroxide 
was likely inducing necrosis in this cell line, given by the fact that cells were never positive only for 
Annx V (Appendix V – Fig. 8.4), which indicates that plasma membrane integrity was compromised. 
4.2.2 CFTR contribution to apoptosis is not by GSH transport through the CFTR pore 
Previous studies indicate that CFTR contribution to ROS-mediated apoptosis is explained by GSH 
transport through the pore, which increases cell susceptibility to oxidative stress53,54. However, in none 
of these studies it was shown what happens when CFTR is stimulated and the pore is opened. Following 
this idea, it is logical to think that if the channel is persistently stimulated, this antioxidant will be 
continuously transported across it, compromising the GSH cytosolic pool and cell survival. An increase 
of the intracellular level of ROS would then activate the ANO6 expressed in this cell line (Fig. 4.11 A) 
and lead to apoptosis. 
To answer this question CFBE wt CFTR cells were stimulated with 100 µM IBMX (3-isobutyl-1-
methylxanthine) and 2 µM FK (Forskolin) for 24h and cell death was accessed by Annx V and 7-AAD 
labeling. IBMX and FK are two different tools used to raise the intracellular level of cAMP and thus 
activate CFTR. However, the persistent CFTR stimulation was not enough to induce apoptosis to a 
significant level (Fig. 4.11 B, C), meaning that opening of CFTR pore is not sufficient to mediate a 
decrease in the intracellular GSH pool/increase in the cytosolic ROS enough to trigger apoptosis.  
 
Figure 3.11. Persistent stimulation of CFTR is not sufficient to trigger spontaneous apoptosis. A) Western Blot of ANO6 
endogenous expression in CFBE wt CFTR cells. B Lymphocytes (B Lymph) were used as a positive control. B) Representative 
original dot-plots of flow cytometry analysis from CFBE wt CFTR cells in the presence or absence of 100 µM IBMX and 2 
µM FK for 24h. C) Summary of Annx V and 7-AAD positivity from experiments shown in B. Long-term supply of high 
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concentrations of cAMP in cells expressing wt CFTR does not lead to spontaneous apoptosis (Values are mean  SEM; n = 
number of experiments). 
This result is also supported by the lack of reduction of tBHP-induced apoptosis in CFBE wt CFTR 
cells by the CFTR-inh 172 (CFTR inhibitor). Indeed, when cells expressing wt CFTR were exposed to 
oxidative stress (100 µM tBHP, 24h) in the presence of the CFTR-inh 172 (5 µM), cell death was not 
reduced, evidenced by Annx V + 7-AAD positivity (Fig. 4.12 A, B). The same was observed in terms 
of cell size on the FSC histograms, where a strong shrinkage was induced by tBHP but not inhibited by 
the CFTR-inh 172 (Fig. 4.12 C).  
 
Figure 3.12. CFTR inhibition does not reduce tBHP-induced cell death. A) Representative original dot-plots of flow 
cytometry analysis from CFBE wt CFTR cells in the presence and absence of 100 µM tBHP or 5 µM CFTR inh-172 for 24h. 
B) Summary of Annx V and 7-AAD positivity of experiments shown in A. C) FSC of experiments shown in A. Inhibition of 
CFTR does not rescue cells from apoptosis. (Values are mean  SEM; # unpaired t-test to control, p-value < 0.05; n = number 
of experiments).
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4. DISCUSSION 
 5.1 ANO6 PLAYS A ROLE DURING ROS-MEDIATED APOPTOSIS 
This work provides evidence that ANO6 is involved in ROS-mediated apoptosis as a Ca2+- activated 
Cl- channel, non-selective cation channel and phospholipid scramblase in two different in vitro systems 
(HEK293 and HeLa cell lines) with two ROS inducers (tBHP and STS). It is first activated during the 
early steps of apoptosis, extruding Cl- and likely cations to the extracellular space. This event may 
contribute to cell shrinkage, which is known to result primarily from a loss of K+ and water82. As the 
intrinsic apoptotic pathway moves forward, the phospholipid scramblase ANO6 function becomes 
relevant, mediating PS exposure in the outer membrane leaflet. 
Although overexpression of this protein augments apoptosis in the presence of ROS, downregulation 
does not rescue cell death, indicating that ANO6 role in this process is not crucial. Additional 
experiments in B lymphocytes support this conclusion, where it was observed that the absence of 
functional ANO6 in Scott cells did not reduce apoptosis induced by STS compared to wt B lymphocytes. 
Nonetheless, wt exhibited a higher % of cells in the early apoptotic stage - Annx V single positive 
(Appendix VI – Fig. 8.5). This result may either imply that Scott cells are more sensitive to STS-
induced apoptosis, undergoing to later stages faster than wt; or that the absence of functional ANO6 
leads to the activation of a different cell death pathway. Indeed, when cells die through the necrotic 
pathway, the membrane integrity is compromised, allowing binding of Annx V and 7-AAD1.  
The fact that ANO6 is not essential to ROS-mediated apoptosis is not surprising since regulated cell 
death is a fundamental process in all living systems, depending on many molecules and cellular 
components5. It is very likely that a cell with no ANO6 compensates this defect with other proteins. In 
addition, Juu et. al defends that the ion channels activated during apoptosis considerably differ between 
cell lines, a phenomenon that may be also true for ANO623. 
5.1.1 ANO6 currents are prior to phospholipid scrambling  
The different timeline between ANO6 activation as an ion channel and phospholipid scramblase 
was already described in a study by Kmit et. al, where elevation of intracellular Ca2+ by ionomycin 
resulted in immediate ANO6 currents but a delayed scrambling34. Here it is shown that the same is true 
when ANO6 is activated by ROS. In particular, tBHP incubation for only 30 min in HEK293 cells 
resulted in an ANO6-dependent Cl- conductance, whereas a differential scrambling was only detected 
after 3h30min.  
It is possible that PS exposure is a consequence of a persistent stimulation of the channel. Indeed, 
patch clamp measurements revealed that activation of ANO6 with high concentrations of Ca2+ or for a 
long period of time results in a current impossible to inhibit (data not shown). It is very likely that only 
on these conditions the channel starts to scramble phospholipids and this may as well be the reason why 
CaCC-AO1, a broad anoctamin inhibitor, was unable to decrease tBHP- induced scrambling in HEK293 
cells (Appendix VII – Fig. 8.6). 
5.1.2 Mechanism of ANO6 activation by ROS 
Phospholipid scrambling can be activated through two distinct pathways: the caspase-dependent 
pathway or by Ca2+ mobilizing agonists15. ANO6 contribution to both processes seems uneven – it is 
very clear that this protein is essential to the Ca2+-mediated PS exposure, however when it comes to 
ANO6 role in the apoptotic induced scrambling, controversial observations emerge. 
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ANO6 is known to be activated by high intracellular Ca2+ concentrations, between 10 and 100 µM22. 
In this regard, ANO6 contribution to Ca2+-mediated PS exposure was also found in this study, when 
overexpression of this protein in HEK293 and HeLa cells resulted in a differential scrambling induced 
by ionomycin (Appendix VIII – Fig. 8.7, 8.8). Here, downregulation of ANO6 by siRNA in HEK293 
cells (Appendix III – Fig. 8.2) significantly reduced the detected scrambling (Appendix VIII – Fig. 
8.7). This is supported by the correspondent experiment in B Lymphocytes (wt vs. Scott), where the 
same observation was done, even though Scott cells still showed a residual scrambling that may be 
explained by the expression of ANO9 known to also act as phospholipid scramblase (Appendix VIII – 
Fig. 8.9). 
During apoptosis, Ca2+ is released as a consequence of intracellular stress by the mitochondria and 
the ER store12. Therefore, the most predictable mechanism of ANO6 activation would be through this 
Ca2+ release detected in apoptotic cells. In fact, Fura-2AM measurements revealed a significant increase 
in the cytosolic Ca2+, after incubation with tBHP in HEK293 cells and STS in HeLa cells (Appendix 
IX – Fig. 8.10). However, the detected concentration of Ca2+ (80 nM and 300 nM, respectively) is not 
sufficient to explain ANO6 activation. Interestingly, incubation with STS in HEK293 cells did not even 
raise the intracellular Ca2+ to a significant level compared to control (Appendix IX – Fig. 8.10). 
Another possible mechanism is related to cell shrinkage and supported by previous findings from 
Martins et. al, where ANO6 was identified as component of the ORCC, a channel known to cause cell 
shrinkage and phospholipid scrambling during apoptosis26. Moreover, Juul et. al found a relationship 
between this protein and caspase-3 activation and thus cell shrinkage23. Hence, it is very likely that the 
same relationship between ANO6, caspase-3 activation and cell shrinkage is applied to ROS-mediated 
apoptosis. This is supported by the finding that HEK293 cells overexpressing ANO6 in the presence of 
tBHP show a considerable difference in the cell size compared to mock cells. 
Interestingly, this year Lalida et. al found an alternative mechanism for ANO6 activation, 
independent of global Ca2+ rising, that relies on plasma membrane conformation. It was proved that the 
cleavage of phospholipids in the plasma membrane, by phospholipase A2 (PLA2), leads to the opening 
of ANO6 pore. This is explained by the release of fatty acids in the cytosol, such as arachidonic acid 
(ArA), and the consequent accumulation of lysophospholipids (LPL) in the membrane. It was 
established that the membrane tension, caused by the presence of LPL, and a local increase of Ca2+ in 
specific domains are the two major players responsible for the activation of ANO6 as an ion channel25. 
ROS are known to induce lipid peroxidation and damage of the plasma membrane83. Therefore, 
another possibility to explain the findings in this work may be associated to membrane tension. This 
hypothesis was also addressed to study tBHP-induced apoptosis in HEK293 cells. In this regard, ACA 
(N-p-Amylcinnamoyl anthranilic Acid), a PLA2 inhibitor, was used as a tool to see if by inhibiting this 
enzyme in the presence of ROS, membrane conformation would be reestablished and scrambling 
reduced. However, this compound revealed to be toxic once applied for a long-term period (data not 
shown). To overcome this problem, ArA was used and expected to compensate the phospholipid 
oxidation during ANO6 activation. This hypothesis was supported by the fact that ArA has been shown 
to inhibit PLA2-induced ANO6 currents25. Here it was found that incubation of ArA in the presence of 
tBHP enhances cell death (Appendix X – Fig. 8.11). Nonetheless, this result does not necessarily 
indicate that this hypothesis is not true, since ArA is also known to be an apoptotic inducer84, responsible 
for the activation of the cyclooxygenase, lipoxygenase and epoxygenase pathways, three major 
mechanisms involved in inflammation. 
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Finally, because LPL was found to activate an anoctamin-dependent conductance in HEK293 
cells25, it was also interesting to look for the effect in scrambling. Incubation of HEK293 with 10 µM 
Lyso-PS (a kind of LPL) for 2h resulted in an increase of Annx V positive cells. However, the detected 
scrambling was not inhibited by downregulation of ANO6 (Appendix III – Fig. 8.2, Appendix X – 
Fig. 8.12). Thus, it is very likely that this effect is due to lysophosphatidic acid (LPA), a downstream 
product of LPL known to induce apoptosis and irrelevant for ANO6 activation25,85. 
As referred before, ROS-mediated cell death is not reduced by CaCC-AO1, however this is not true 
when it comes to tannic acid (TA). Tannic acid is a polyphenolic biomolecule known to bind to proteins, 
such as ANO6, and stabilize biological membranes. Remarkably, when applied to HEK293 cells in the 
presence of tBHP, TA reduced the % of Annx V + 7-AAD positive cells, by a 3-fold factor (Appendix 
X – Fig. 8.13). This strong inhibition is likely through membrane stabilization and protection of lipid 
oxidation, which is in agreement with the alternative mechanism found by Lalida et. al25. 
5.2 CFTR PLAYS A ROLE DURING ROS-MEDIATED APOPTOSIS 
As outlined in the Introduction chapter, CFTR is described by many as a pro-apoptotic factor 
involved in the regulation of the intracellular redox status, acidification and ceramide content in lipid 
rafts49,52–54,56,59–61. The apoptotic process in CF has been studied over the years and, although some 
conclusions are controversial, it seems that a defect on the clearance of apoptotic cells contribute to the 
ongoing inflammations and tissue injury48. Also, oxidative stress and infections are two major mediators 
of pulmonary damage which results in necrosis of lung epithelial cells54. 
In the present project CFTR function was studied in HEK293 and CFBE cells. In the first cell line, 
this protein was shown to enhance STS-mediated phospholipid scrambling and to have a Cl- conductance 
during ROS-mediated apoptosis. Likewise, studies in the CFBE cell line provided evidence that CFTR 
helps cells to undergo apoptosis once exposed to oxidative stress. Because the mutant CFTR form 
(ΔF508) rescues partially cells from tBHP-induced apoptosis it is concluded that the presence of this 
protein in the plasma membrane is essential. 
However, unlike what it is reported in previous studies53, here it was found that CFTR contribution 
to ROS-mediated apoptosis is independent of channel activation and pore opening. Indeed, persistent 
stimulation of CFTR by supply of cAMP with IBMX and FK did not result in spontaneous apoptosis of 
CFBE cells. Also, tBHP-induced cell death was not reduced by the CFTR-inh 172. A high concentration 
of cytosolic ROS is known, not only to decrease GSH levels, but also to induce GSH transport to the 
extracellular space50. Therefore, it is possible that GSH permeation across CFTR only happens in the 
presence of intracellular oxidative stress. This might explain why it was detected a substantial difference 
in tBHP-induced apoptosis between the wt and ΔF508 CFTR forms, but persistent stimulation of the 
channel did not lead to cell death to a detectable level. It is also possible that the differential susceptibility 
of the two CFBE variants to ROS is related to intracellular acidification. In fact, measurements done in 
a study from Jungas et.al led to the conclusion that cells expressing wt CFTR have a lower intracellular 
pH in the presence of H2O2 compared to ΔF508 CFTR54. 
Remarkably, here CFTR was also found to contribute to cell shrinkage induced by tBHP. This result 
resembles ANO6 role in tBHP-induced apoptosis of HEK293 cells and is in agreement with previous 
studies where CFTR is reported to contribute to cell shrinkage53 and to act as volume-regulated Cl- 
channel82. 
The apoptotic dysfunction in CF is hard to establish because CF epithelial cells are characterized by 
an accentuated ER stress48. Understanding this particularity of the disease may help to control the 
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inflammatory process in CF, a symptom that remains one of the major unresolved problems. It is 
believed that in the presence of a specific stimulus, cells expressing a mutant CFTR form have a higher 
tendency to undergo necrosis54. One of the characteristics of the necrotic cell death is the release of 
DNA debris that initiate inflammatory responses. On the contrary, if cells die through the apoptotic 
pathway, fragmented DNA is tightly packed in apoptotic bodies which are then phagocytosed, protecting 
the surrounding tissue from inflammations54. 
Indeed, large DNA fragments are found in the lung epithelia from CF patients55, supporting this 
concept. Remarkably, additional experiments in this study can be also taken as a hint that this is true. 
Particularly, the over-time response of CFBE cells to H2O2 revealed that cells expressing the mutant 
CFTR had a significantly higher population of cells positive for 7-AAD in the presence of the ROS 
inducer, compared to wt CFTR (Appendix V – Fig. 8.4). Single binding of 7-AAD to the nucleus is not 
a common event, happening once cell morphology is completely damaged and degraded. This may 
indicate that stimulation of cells with ROS without CFTR in the membrane results in a burst of the dying 
cell. 
5.3 ANO6 AND CFTR ARE CO-WORKERS DURING REGULATED CELL DEATH 
The hypothesis that ANO6 and CFTR cooperate during apoptosis emerged from previous reports 
where ROS was suspected to have an influence in ANO6 activity22,26 and CFTR was described to 
mediate GSH efflux49. Moreover, a functional relationship between these two channels was also 
described26. 
In this study it is proved that ANO6 and CFTR interact during ROS-mediated apoptosis. This is 
supported by experiments in HEK293 cells where co-expression of these proteins resulted in a two-fold 
increase of Annx V positive cells after exposure to STS, compared to single transfection groups. 
Furthermore, it was demonstrated that ANO6 and CFTR co-expression results in a significant 
spontaneous apoptosis, that is in the absence of any oxidative stress inducer. 
Additionally, separate experiments of ANO6 and CFTR function during apoptosis point out for a 
contribution of these two proteins to cell shrinkage, a process dependent on the activation of ion 
channels. Also, overexpression of ANO6 or CFTR and exposure to STS in HEK293 cells significantly 
augmented the basal current, compared to mock-transfected cells. Because this effect is stronger for 
ANO6, it is speculated that CFTR expression enhances this current. Nonetheless, Martins et. al found 
that cAMP- induced CFTR currents can be inhibited by downregulation of ANO6, suggesting that the 
two mechanisms can occur26. 
In conclusion, exposure of cells to oxidative stress and consequent ROS production leads to 
mitochondrial permeabilization, release of Ca2+ and pro-apoptotic proteins, responsible for caspase 
cleavage. These events terminate with ANO6 activation, which may support cell shrinkage and 
phospholipid scrambling, two apoptotic hallmarks enhanced in the presence of CFTR (Fig. 5.1). 
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Figure 4.1. Proposed role of ANO6 and CFTR in apoptotic cell death. CFTR and ANO6 are two independent channels with 
a functional relationship during regulated cell death. Oxidative stress leads to mitochondrial permeabilization, release of Ca2+ 
and cytochrome c, which will lead to caspase-9 and 3 activation. ANO6 may support cell shrinkage and phospholipid 
scrambling, two activities enhanced in the presence of CFTR. 
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5. FUTURE PERSPECTIVES  
Understanding the interaction of ANO6 and CFTR during regulated cell death may help to control 
CF apoptotic dysfunction and inflammations. For this reason, it is strongly encouraged that these 
investigations are pursued in an attempt to gain knowledge about the molecular mechanism behind this 
functional interaction. 
Regarding ANO6 role in ROS-mediated apoptosis, further studies in B Lymphocytes are required. 
One possibility is the analysis of the parallel response of wt and Scott cells to STS by flow cytometry 
measurements of Annx V and 7-AAD labeling. This experiment may help to test the hypothesis that the 
absence of functional ANO6 leads to the activation of a different cell death pathway. PLA2 inhibitors 
and ArA can also be tested by path clamp experiments in order to understand if the ROS-induced basal 
apoptotic current can be inhibited by a reduction of the plasma membrane tension.  
Concerning CFTR involvement in apoptosis, it would be interesting to mimic inflammatory CF 
conditions in the CFBE in vitro system and look if the susceptibility to cell death is still dependent on 
the CFTR expression on the membrane. Similar experiments could be also done in primary cultured 
cells isolated from airways of an animal model (wt or knocked-out for CFTR), where spontaneous 
apoptosis could be evaluated by a simple caspase-3 assay.  
Because it was concluded that CFTR involvement in tBHP-induced cell death cannot be explained 
by cAMP-channel activation, thorough studies of the effect of ROS in CFTR activity could unravel why 
CFBE wt CFTR cells are more susceptible to ROS-mediated apoptosis. Firstly, it would be interesting 
to patch this cell line in the presence of tBHP and look for a CFTR current, which may or may not be 
inhibited by the CFTR-inh 172. Additionally, measurements of the intracellular pH could prove if CFTR 
contribution to intracellular acidification is a factor during tBHP-induced apoptosis. Although persistent 
channel stimulation did not result in cell death, one can look for glutathione or ROS levels of CFBE 
cells in the presence or absence of IBMX and FK. 
The major breakthrough of this project was the evidence that ANO6 and CFTR cooperate during 
regulated cell death. In this regard a co-immunoprecipitation or a FRET (Förster resonance energy 
transfer) analysis can be performed to prove an interaction between these two proteins. Additionally, 
because it is suggested that CFTR may enhance ANO6 function, a biotinylation of ANO6 endogenous 
membrane expression in CFBE cells would be also interesting. By this experiment it would be possible 
to compare if CFTR trafficking defects also affect ANO6 expression in the plasma membrane. 
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7. APPENDICES 
APPENDIX I – CDNA  
Table 7.1 Plasmids accession number and base pairs (bp). 
Target Accession number bp 
ANO6 NM_001025356 27306 
CFTR NM_000492 4440 
 
APPENDIX II - INHIBITION OF TBHP-INDUCED APOPTOSIS BY IDEBENONE 
 
 
Figure 7.1. Inhibition of tBHP-induced apoptosis by Idebenone. A) Representative original dot-plots of flow cytometry 
analysis of HEK293 cells in the presence or absence of tBHP (100 µM) and/or Idebenone (20 µM) for 2h. B) Summary of 
Annx V and 7-AAD positivity of experiments shown in A. Idebenone significantly reduced Annx V and 7-AAD positive cells 
in the presence of tBHP, rescuing ROS-mediated cell death. (Values are mean ± SEM; # unpaired t-test to control, # unpaired 
t-test to tBHP treated cells, p-value < 0.05; n = number of experiments). 
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APPENDIX III – DOWNREGULATION OF ANO6 IN HEK293 AND HELA CELLS 
 
Figure 7.2. Western Blot analysis of ANO6 expression in HEK293 (A) and HeLa (B) cells, after 48h and 24h of transfection 
with siRNA, respectively. 
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APPENDIX IV – EFFECT OF ANO6 SILENCING ON TBHP-INDUCED APOPTOSIS OF 
HEK293 CELLS 
 
Figure 7.3. ANO6 silencing increases the tBHP-induced apoptosis in HEK293 cells. A) Representative original dot-plots 
of cells transfected with siANO6 or scrambled in the presence or absence of 100 µM tBHP for 3h30. B) Summary of Annx V 
and Annx V + 7-AAD positivity of experiments shown in A. Downregulation of ANO6 likely resulted in off target effects, 
enhancing cell death induced by tBHP. (Values are mean ± SEM; # unpaired t-test to control, # unpaired t-test to scrambled 
treated cells, p- value < 0.05; n = number of experiments). 
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APPENDIX V - EFFECT OF CFTR IN H2O2-INDUCED CELL DEATH OF CFBE 
CELLS 
 
Figure 7.4. CFBE cells expressing wt CFTR have a higher susceptibility to H2O2-induced cell death. A) Representative 
original dot-plots from over-time response to 900 µM H2O2 (0h, 2h, 4h, 8h) of CFBE wt and ΔF508 CFTR cells. B) Summary 
of 7-AAD and Annx V + 7-AAD positivity of experiments shown in A. C) FSC histograms of experiments shown in A. (Values 
are mean ± SEM; # unpaired t-test to control, # unpaired t-test to H2O2 to CFBE wt CFTR treated cells, p-value < 0.05; n = 
number of experiments). 
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APPENDIX VI – EFFECT OF STS IN WT AND SCOTT B LYMPHOCYTES 
 
Figure 7.5. STS induces a differential Annx V positivity in wt and Scott lymphocytes. A) Representative original dot-plots 
of flow cytometry analysis of wt and Scott lymphocytes non-treated and treated with 1 µM STS for 16h, B) Summary of Annx 
V and Annx V + 7-AAD positivity of experiments shown in A. (Values are mean ± SEM; # unpaired t-test to control, # unpaired 
t-test to wt B lymphocytes incubated with STS, p-value < 0.05; n = number of experiments). 
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APPENDIX VII - CACC-AO1 DOES NOT INHIBIT TBHP-INDUCED APOPTOSIS OF 
HEK293 CELLS 
 
Figure 7.6. Effect of CaCC-AO1 in tBHP-induced apoptosis of HEK293 cells. A) Representative original dot-plots of flow 
cytometry analysis from HEK293 cells in the presence or absence of 100 µM tBHP and 20 µM CaCC-AO1 for 2h. B) Summary 
of Annx V and 7-AAD positivity of experiments shown in A. Inhibition of ANO6 by CaCC-AO1 does not rescue cells from 
tBHP induced apoptosis. (Values are mean ± SEM; # unpaired t-test to control, p-value < 0.05; n = number of experiments). 
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APPENDIX VIII - ANO6 IS ESSENTIAL FOR CA2+-INDUCED SCRAMBLING 
 
Figure 7.7. Ionomycin induces an ANO6-dependent phospholipid scrambling in HEK293 cells. A) Representative original 
dot-plots from flow cytometry analysis of HEK293 cells transfected with mock, ANO6, scrambled or siANO6 and stimulated 
for 20 min with 1 µM Iono. B) Summary of Annx V positivity from experiments shown in A. (Values are mean ± SEM; # 
unpaired t-test to control, # unpaired t-test to mock-transfected cells in the presence of Iono, # unpaired t-test to scrambled-
transfected cells in the presence of Iono, p-value < 0.05; n = number of experiments). 
 
Figure 7.8. Ionomycin induces an ANO6-dependent phospholipid scrambling in HeLa cells. A) Representative original 
dot-plots from flow cytometry analysis of HeLa cells transfected with mock or ANO6 and stimulated for 30 min with 10 µM 
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Iono. B) Summary of Annx V positivity from experiments shown in A. (Values are mean ± SEM; # unpaired t-test to control, 
# unpaired t-test to mock-transfected cells in the presence of Iono, p-value < 0.05; n = number of experiments). 
 
Figure 7.9. Ionomycin induces an ANO6-dependent phospholipid scrambling in B lymphocytes. A) Representative 
original dot-plots from flow cytometry analysis of wt and Scott Lymphocytes stimulated for 10 min with 5 µM Iono. B) 
Summary of Annx V positivity from experiments shown in A. (Values are mean ± SEM; # unpaired t-test to control, # unpaired 
t-test to wt B lymphocytes in the presence of Iono, p-value < 0.05; n = number of experiments). 
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APPENDIX IX – INTRACELLULAR CA2+ CONCENTRATION DURING ROS-
MEDIATED APOPTOSIS 
 
Figure 7.10. ROS effect in intracellular Ca2+ concentration. A)  Fura-2 AM measurements of HEK293 cells in the presence 
or absence of 100 µM tBHP for 1h30. B) Fura-2 AM measurements of HEK293 cells in the presence or absence of 1 µM STS 
for 24h. C) Fura-2 AM measurements of HeLa cells in the presence or absence of 1 µM STS for 5h. Intracellular Ca2+ is 
significantly increased by tBHP in HEK293 cells and STS in HeLa cells. Incubation with STS in HEK293 cells did not affect 
[Ca2+]i. (Values are mean ± SEM; # unpaired t-test to control, p-value < 0.05; n = number of experiments). 
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APPENDIX X – PLASMA MEMBRANE TENSION IN ROS-MEDIATED APOPTOSIS 
 
Figure 7.11. Arachidonic acid enhances tBHP-induced apoptosis. A) Representative original dot-plots of HEK293 cells in 
the presence or absence of 100 µM tBHP and 20 µM ArA for 2h. B) Summary of Annx V and Annx V + 7-AAD positivity of 
experiments shown in A. (Values are mean ± SEM; # unpaired t-test to control, # unpaired t-test to tBHP-treated cells, p-value 
< 0.05; n = number of experiments). 
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Figure 7.12. LPL induces an ANO6-independent PS exposure in HEK293 cells. A) Representative original dot-plots of 
HEK293 cells transfected with scrambled or siANO6, in the presence/absence of 10 µM Lyso-phosphatidylserine (Lyso-PS) 
for 2h. B) Summary of Annx V positivity of experiments shown in A. (Values are mean ± SEM; # unpaired t-test to control, 
p-value < 0.05; n = number of experiments). 
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Figure 7.13. Tannic acid inhibits tBHP-induced apoptosis. A) Representative original dot-plots of HEK293 cells in the 
presence or absence of 100 µM tBHP and 1 µM TA for 2h. B) Summary of Annx V and Annx V + 7-AAD positivity of 
experiments shown in A. (Values are mean ± SEM; # unpaired t-test to control, # unpaired t-test to tBHP-treated cells, p-value 
< 0.05; n = number of experiments). 
 
 
 
